Other

Net interest and investment income (loss)

Vertex Pharmaceuticals Net interest and investment income (loss) decreased by 2.6% to $114.80M in Q1 2026 compared to the prior quarter.

Analysis

StatementIncome Statement
SectionOther
First reportedQ1 2025
Last reportedQ1 2026May 5, 2026
Metric ID: other_investment_income_net

Historical Data

2 periods
 Q1 '25Q1 '26
Value$117.90M$114.80M
QoQ Change—-2.6%
YoY Change—-2.6%
Range$114.80M – $117.90M
Avg YoY Growth-2.6%
Median YoY Growth-2.6%

Business Segments

View all
SegmentQ1 '26
Pharmaceuticals$114.80M
Total$114.80M

Frequently Asked Questions

What is Vertex Pharmaceuticals's net interest and investment income (loss)?
Vertex Pharmaceuticals (VRTX) reported net interest and investment income (loss) of $114.80M in Q1 2026.